- Home
- SBH vs CDNA Comparison
SBH vs CDNA Comparison
Compare SBH & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- CDNA
- Stock Information
- Founded
- SBH 1964
- CDNA 1998
- Country
- SBH United States
- CDNA United States
- Employees
- SBH N/A
- CDNA N/A
- Industry
- SBH Other Specialty Stores
- CDNA Medical Specialities
- Sector
- SBH Consumer Discretionary
- CDNA Health Care
- Exchange
- SBH Nasdaq
- CDNA Nasdaq
- Market Cap
- SBH 1.1B
- CDNA 1.1B
- IPO Year
- SBH 2006
- CDNA 2014
- Fundamental
- Price
- SBH $11.26
- CDNA $21.44
- Analyst Decision
- SBH Buy
- CDNA Buy
- Analyst Count
- SBH 6
- CDNA 8
- Target Price
- SBH $13.60
- CDNA $26.43
- AVG Volume (30 Days)
- SBH 2.1M
- CDNA 842.2K
- Earning Date
- SBH 01-30-2025
- CDNA 02-26-2025
- Dividend Yield
- SBH N/A
- CDNA N/A
- EPS Growth
- SBH N/A
- CDNA N/A
- EPS
- SBH 1.43
- CDNA N/A
- Revenue
- SBH $3,717,031,000.00
- CDNA $312,775,000.00
- Revenue This Year
- SBH $2.07
- CDNA $19.85
- Revenue Next Year
- SBH $1.58
- CDNA $11.34
- P/E Ratio
- SBH $7.80
- CDNA N/A
- Revenue Growth
- SBH N/A
- CDNA 5.26
- 52 Week Low
- SBH $9.06
- CDNA $7.42
- 52 Week High
- SBH $14.79
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- SBH 46.00
- CDNA 43.79
- Support Level
- SBH $10.81
- CDNA $21.09
- Resistance Level
- SBH $11.48
- CDNA $25.95
- Average True Range (ATR)
- SBH 0.45
- CDNA 1.61
- MACD
- SBH 0.12
- CDNA 0.02
- Stochastic Oscillator
- SBH 85.81
- CDNA 19.46
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Colombia, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.